Literature DB >> 1095806

Dense deposit disease: a variant of membranoproliferative glomerulonephritis.

R Habib, M C Gubler, C Loirat, H B Mäiz, M Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095806     DOI: 10.1038/ki.1975.32

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  37 in total

1.  Circulating and deposited immune complexes in renal disease and their clinical correlation.

Authors:  S L Cohen; C Fisher; J F Mowbray; A Hopp; J Burton-Kee
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

2.  Kidney tubule basement membrane alterations in type II membranoproliferative glomerulonephritis.

Authors:  M V Campbell-Boswell; D Linder; B R Naylor; R E Brooks
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-05-14

Review 3.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

4.  A case of regression of atypical dense deposit disease without C3 deposition in a child.

Authors:  Min Sun Kim; Pyoung Han Hwang; Mung Jae Kang; Dae-Yeol Lee
Journal:  Korean J Pediatr       Date:  2010-07-31

5.  Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG).

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Hiroshi Kaito; Ryojiro Tanaka; Koichi Nakanishi; Masafumi Matsuo; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2007-08-03       Impact factor: 3.714

6.  Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.

Authors:  B K Davis; T Cavallo
Journal:  Am J Pathol       Date:  1976-08       Impact factor: 4.307

7.  Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J Bernstein; J N Tobin; C M Edelmann
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

8.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Authors:  M A Abrera-Abeleda; C Nishimura; J L H Smith; S Sethi; J L McRae; B F Murphy; G Silvestri; C Skerka; M Józsi; P F Zipfel; G S Hageman; R J H Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

Review 9.  Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-07-06

Review 10.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.